Tower Research Capital (TRC)’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$16.5M Buy
67,436
+6,895
+11% +$1.61M 0.43% 30
2025
Q4
$12.5M Sell
60,541
-2,838
-4% -$561K 0.3% 50
2025
Q3
$11.8M Sell
63,379
-23,168
-27% -$3.97M 0.32% 44
2025
Q2
$13.2M Sell
86,547
-42,133
-33% -$6.48M 0.36% 37
2025
Q1
$21.2M Sell
128,680
-30,145
-19% -$4.72M 0.63% 18
2024
Q4
$23M Buy
158,825
+66,143
+71% +$10.2M 0.46% 29
2024
Q3
$15M Sell
92,682
-2,353
-2% -$375K 0.4% 31
2024
Q2
$13.9M Buy
95,035
+8,584
+10% +$1.28M 0.23% 59
2024
Q1
$13.7M Sell
86,451
-264,840
-75% -$42.2M 0.33% 47
2023
Q4
$55.1M Buy
351,291
+251,420
+252% +$38.6M 0.68% 17
2023
Q3
$15.6M Buy
99,871
+61,478
+160% +$10.1M 0.49% 25
2023
Q2
$6.35M Sell
38,393
-21,623
-36% -$3.49M 0.21% 60
2023
Q1
$9.3M Buy
60,016
+10,907
+22% +$1.76M 0.3% 37
2022
Q4
$8.68M Sell
49,109
-203,371
-81% -$35.1M 0.36% 29
2022
Q3
$41.2M Buy
252,480
+98,512
+64% +$16.7M 0.67% 18
2022
Q2
$27.3M Sell
153,968
-261,347
-63% -$46.6M 0.61% 20
2022
Q1
$73.6M Buy
415,315
+244,134
+143% +$41.5M 0.7% 19
2021
Q4
$29.3M Buy
171,181
+100,050
+141% +$16.4M 0.51% 30
2021
Q3
$11.5M Sell
71,131
-31,752
-31% -$5.42M 0.29% 41
2021
Q2
$16.9M Sell
102,883
-199,946
-66% -$33.1M 0.44% 27
2021
Q1
$49.8M Buy
302,829
+221,365
+272% +$35.8M 0.84% 13
2020
Q4
$12.8M Buy
81,464
+21,780
+36% +$3.21M 0.39% 20
2020
Q3
$8.89M Sell
59,684
-7,133
-11% -$1.06M 0.1% 31
2020
Q2
$9.4M Buy
66,817
+63,547
+1,943% +$9.26M 0.39% 21
2020
Q1
$429K Buy
+3,270
New +$464K 0.03% 479
2019
Q4
Sell
-37,148
Closed -$4.81M 3945
2019
Q3
$4.81M Buy
37,148
+23,211
+167% +$3.06M 0.33% 39
2019
Q2
$1.94M Sell
13,937
-29,452
-68% -$4.08M 0.13% 120
2019
Q1
$6.07M Sell
43,389
-35,297
-45% -$4.73M 0.37% 23
2018
Q4
$10.2M Buy
78,686
+13,580
+21% +$1.89M 0.73% 14
2018
Q3
$9M Sell
65,106
-61,532
-49% -$8.18M 0.66% 16
2018
Q2
$15.4M Buy
126,638
+126,338
+42,113% +$15.8M 0.86% 13
2018
Q1
$38K Sell
300
-46,699
-99% -$6.31M ﹤0.01% 1824
2017
Q4
$6.57M Buy
+46,999
New +$6.55M 0.85% 13
2017
Q3
Sell
-25,538
Closed -$3.38M 3979
2017
Q2
$3.38M Buy
+25,538
New +$3.26M 0.38% 41
2017
Q1
Sell
-70,388
Closed -$8.11M 3488
2016
Q4
$8.11M Buy
70,388
+63,734
+958% +$7.36M 0.88% 8
2016
Q3
$786K Sell
6,654
-14,243
-68% -$1.73M 0.08% 103
2016
Q2
$2.54M Buy
20,897
+13,598
+186% +$1.55M 0.24% 74
2016
Q1
$790K Buy
7,299
+7,199
+7,199% +$745K 0.12% 132
2015
Q4
$10K Buy
+100
New +$10.1K ﹤0.01% 2122
2015
Q3
Sell
-4,308
Closed -$420K 4387
2015
Q2
$420K Buy
4,308
+4,138
+2,434% +$414K 0.04% 163
2015
Q1
$17K Sell
170
-4,081
-96% -$415K ﹤0.01% 2377
2014
Q4
$445K Sell
4,251
-20,337
-83% -$2.14M 0.04% 138
2014
Q3
$2.62M Buy
24,588
+20,015
+438% +$2.08M 0.29% 62
2014
Q2
$478K Sell
4,573
-16,774
-79% -$1.7M 0.06% 275
2014
Q1
$2.1M Buy
21,347
+13,003
+156% +$1.21M 0.27% 70
2013
Q4
$764K Sell
8,344
-29,392
-78% -$2.71M 0.13% 114
2013
Q3
$3.27M Buy
37,736
+36,891
+4,366% +$3.31M 0.35% 56
2013
Q2
$73K Buy
+845
New +$71.7K 0.01% 672

Other funds holding JNJ

Tower Research Capital (TRC)'s JNJ Position: Q1 2026 in Review

Tower Research Capital (TRC) increased its Johnson & Johnson (JNJ) stake by 11% in Q1 2026, buying an estimated $1.61M and bringing the position to 67,436 shares worth $16.5M. The position accounts for 0.43% of the portfolio, ranked #30.

Tower Research Capital (TRC) first reported a position in JNJ in Q2 2013 and has held it in 48 quarters since. The position peaked at $73.6M in Q1 2022. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Tower Research Capital (TRC) held 67,436 shares of Johnson & Johnson worth $16.5M as of Q1 2026.
  • Tower Research Capital (TRC) bought 6,895 Johnson & Johnson shares in Q1 2026, an estimated $1.61M.
  • Johnson & Johnson made up 0.43% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #30 holding.
  • Tower Research Capital (TRC) first reported a position in Johnson & Johnson in Q2 2013 and has held it in 48 quarters since.
  • Tower Research Capital (TRC)'s Johnson & Johnson position peaked at $73.6M in Q1 2022.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.